SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 29 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $248,000 | -22.7% | 1,165,836 | +3.3% | 0.00% | – |
| Q1 2022 | $321,000 | +21.1% | 1,128,121 | +15.5% | 0.00% | – |
| Q4 2021 | $265,000 | -40.8% | 976,316 | 0.0% | 0.00% | – |
| Q3 2021 | $448,000 | -22.2% | 976,316 | +2.1% | 0.00% | – |
| Q2 2021 | $576,000 | -1.7% | 956,281 | +11.1% | 0.00% | – |
| Q1 2021 | $586,000 | +9666.7% | 860,418 | +4779.6% | 0.00% | – |
| Q4 2020 | $6,000 | -25.0% | 17,633 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | -11.1% | 17,633 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +80.0% | 17,633 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -68.8% | 17,633 | -50.0% | 0.00% | – |
| Q4 2019 | $16,000 | +100.0% | 35,266 | +100.0% | 0.00% | – |
| Q3 2019 | $8,000 | -11.1% | 17,633 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -18.2% | 17,633 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | -38.9% | 17,633 | -50.0% | 0.00% | – |
| Q4 2018 | $18,000 | -60.0% | 35,266 | +100.0% | 0.00% | – |
| Q3 2018 | $45,000 | -69.4% | 17,633 | -97.1% | 0.00% | – |
| Q2 2018 | $147,000 | – | 617,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 903,741 | $497,000 | 0.62% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,750,000 | 0.04% |
| WEDBUSH SECURITIES INC | 97,957 | $54,000 | 0.01% |
| SCOPUS ASSET MANAGEMENT, L.P. | 225,000 | $124,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,000 | $33,000 | 0.00% |
| 683 Capital Management, LLC | 42,858 | $24,000 | 0.00% |
| UBS Group AG | 600 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
| Advisor Group, Inc. | 421 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 316 | $0 | 0.00% |